{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["1,2,3-Triazole", "Alzheimer\u2019s disease", "Docking study", "Dual binding site", "Morris water maze", "Tacrine-Coumarins"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30396115", "DateCompleted": {"Year": "2020", "Month": "01", "Day": "07"}, "DateRevised": {"Year": "2020", "Month": "01", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "10", "Day": "28"}], "Language": ["eng"], "ELocationID": ["10.1016/j.bioorg.2018.10.056", "S0045-2068(18)30887-3"], "Journal": {"ISSN": "1090-2120", "JournalIssue": {"Volume": "83", "PubDate": {"Year": "2019", "Month": "Mar"}}, "Title": "Bioorganic chemistry", "ISOAbbreviation": "Bioorg Chem"}, "ArticleTitle": "Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study.", "Pagination": {"StartPage": "303", "EndPage": "316", "MedlinePgn": "303-316"}, "Abstract": {"AbstractText": ["A new series of tacrine-coumarin hybrids linked to 1,2,3-triazole were designed, synthesized, and tested as potent dual binding site cholinesterase inhibitors (ChEIs) for the treatment of Alzheimer's disease (AD). Among them, compound 8e was the most potent anti-AChE derivative (IC<sub>50</sub>\u202f=\u202f27\u202fnM) and compound 8m displayed the best anti-BChE activity (IC<sub>50</sub>\u202f=\u202f6\u202fnM) much more active than tacrine and donepezil as the reference drugs. Compound 8e was also evaluated for its BACE1 inhibitory activity and neuroprotectivity against PC12 cells exposed to A\u03b2<sub>25-35</sub> which indicated low activity. Finally, in vivo studies by Morris water maze task showed that compound 8e significantly reversed scopolamine-induced memory deficit in rats."], "CopyrightInformation": "Copyright \u00a9 2018. Published by Elsevier Inc."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Department of Medicinal Chemistry, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Najafi", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Mahdavi", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Saeedi", "ForeName": "Mina", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Karimpour-Razkenari", "ForeName": "Elahe", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Edraki", "ForeName": "Najmeh", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Sharifzadeh", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Khanavi", "ForeName": "Mahnaz", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: akbarzad@tums.ac.ir."}], "LastName": "Akbarzadeh", "ForeName": "Tahmineh", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Bioorg Chem", "NlmUniqueID": "1303703", "ISSNLinking": "0045-2068"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Coumarins"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Nootropic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Triazoles"}, {"RegistryNumber": "4VX7YNB537", "NameOfSubstance": "Tacrine"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Butyrylcholinesterase"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Butyrylcholinesterase"}, {"QualifierName": [], "DescriptorName": "Catalytic Domain"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["chemical synthesis", "metabolism", "pharmacology", "therapeutic use"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": ["chemical synthesis", "metabolism", "pharmacology", "therapeutic use"], "DescriptorName": "Coumarins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Maze Learning"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemical synthesis", "metabolism", "pharmacology", "therapeutic use"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["chemical synthesis", "metabolism", "pharmacology", "therapeutic use"], "DescriptorName": "Nootropic Agents"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["analogs & derivatives", "chemical synthesis", "metabolism", "therapeutic use"], "DescriptorName": "Tacrine"}, {"QualifierName": [], "DescriptorName": "Torpedo"}, {"QualifierName": ["chemical synthesis", "metabolism", "pharmacology", "therapeutic use"], "DescriptorName": "Triazoles"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "8", "Day": "16"}, {"Year": "2018", "Month": "10", "Day": "10"}, {"Year": "2018", "Month": "10", "Day": "27"}, {"Year": "2018", "Month": "11", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "6", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30396115", "10.1016/j.bioorg.2018.10.056", "S0045-2068(18)30887-3"]}}]}